Reward and Substance use Flashcards

1
Q

Drugs of abuse: what are the major stimulants?

A

Narcotics
Cannabis
Nicotine & Alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Stimulants do what ?

A

arouses or accelerates activities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the ampthemines?

A

Amphetamine derivatives - methamphetamine (“Ice”), Methylenedioxymethamphetamine (MDMA, “E”), Methylenedioxyethylamphetamine (MDEA), Methylenedioxyamphetamine (MDA), Paramethoxyamphetamine (PMA, “death”)

Methylphenidate (Ritalin for ADHD)
* Nicotine (Tobacco)
* Psychostimulant: stimulates the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What do the narcotics due ?

A

nduces narcosis (sleep or stupor) = numbing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give examples of narcotics?

A

Opium, Heroin (metabolised to morphine in CNS)
* Morphine
* Methadone
* Fentanyl
* Hydromorphone
* Meperidine
* Codeine
* Oxycodone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What do they Hallucinogens due?

A

produce hallucinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give eg of Hallucinogens

A

MDMA (“E”)
* Lysergic Acid Diethylamide (LSD “Acid”)
* 2,5-dimethoxy-4-iodoamphetamine (DOI)
* Phencyclidine (PCP , “angel dust”)
* Psilocybin (“magic” mushrooms)
* Mescaline (peyote cactus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Drug Use Statistics:
Australian Institute of Health and Welfare

See slide 8

A

More older people taking drugs now in over 40’s ( 2001-2019)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Illicit Drug use in Youth, USA

see slide 9

A

slow INC from 8-12 grade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drug Use Statistics:
Change in use from 2016 to

see slide 10

A

*amphetamine use is stable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Increase in “E “ use in males

See graph p11

A

upwards swing since 2016

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Methamphetamine use is stable BUT
more potent forms used from 2013

Methamphetamine use is stable BUT
it is used at high frequently

see p 12- 13

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why do we take drugs?

A

Curiosity/ offered it/ exciting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do we continue?

A

Enjoyinh/ fun
enhance experience
exciting / improves mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

**Re -visit reward pathway: slides 17- 23

A

Nucleus accumbens (NA): Major Reward Area
Ventral Tegmental Area: VTA, Dopamine cell bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Effects of stimulants ?

A

Euphoria & well-being
* Increased alertness
* Increased self-confidence * Increased energy

Ecstasy (MDMA) is also an ENTACTOGEN (touchy feely) - promotes closeness to others

16
Q

See Diagrams: Phamacology of diff drugs: slide 25-29

A
17
Q

5 Side effects of stimulant use ?

A
  • Seizures
  • Depression & Anxiety
  • Paranoia
  • Psychosis
  • Neurotoxicity
18
Q

Pharmocology of Cannabis?

A

Active constituent of Cannabis is D9-Tetrahydrocannabinol (THC) THC binds to Cannabinoid receptors to increase DA release
in the nucleus accumbens
Cannabinoid receptors: CB1 & CB2 Anandamide is the natural ligand for these receptors

19
Q

Effects of Cannabis

A

Cortex: motor/sensory,
Cingulate cortex: judgement
Hippocampus: blunts memory,
Cerebellum: blunts motor coordination

20
Q

Pharmacology of Nicotine & Alcohol

A

Both increase dopamine release in nucleus accumbens by modulation of different receptor types:
* Nicotine - Nicotinic receptors (Acetylcholine)
* Alcohol - GABA-A receptor agonist
NMDA glutamate receptor antagonist
Modulates opioid peptide system (mu receptors)

21
Q

Summary

A

All drugs of abuse are rewarding: * Euphoria
* Excitement
* Relaxation
All drugs of abuse increase DA in the Nucleus Accumbens * Cocaine blocks the DAT
* Amphetamines reverse the DAT
* MDMA (Ecstasy) reverses the SERT
* Cannabis increases DA via Cannabinoid receptors
* Nicotine increases DA via nicotinic receptors
* Alcohol increases DA via GABA-A and NMDA receptors
* All drugs of abuse have serious side effects from repeated use Ø ADDICTION
Ø PSYCHOSIS, DEPRESSION & ANXIETY

22
Q

Chronic drug effects

A

Psychostimulant abuse:

Paranoid psychosis Similar to schizophrenic

Seizures

Depression Anxiety Parkinson’s like symptoms (MPTP)

22
Q

Chronic drug effects

A

Psychostimulant abuse:

Paranoid psychosis Similar to schizophrenic

Seizures

Depression Anxiety Parkinson’s like symptoms (MPTP)

23
Q

Review slides re drug effects on Serotonin transporters: slide 36- 39

A
24
Q

Symptoms of repeated Ecstasy use?

A
  • Depleted stores of serotonin in the terminals - Neurotoxicity(death) of serotonin cell terminals
  • Chronic depressive and/or anxiety states
25
Q

what drug caused reductions in social interaction?

A

MDMA

26
Q

what are long term effects of MDMA?

A

INC anxiety

27
Q

Outline effects of Methamphetamine & Neurotoxicity

A

Large doses and prolonged use of MDMA (ecstasy) result in the neurotoxicity of serotonin neurons
- Methamphetamine may also produce depletions in serotonin > depressive and anxiety symptoms
Methamphetamine has a greater effect on dopamine neurons
* Neurotoxicity of dopamine neurons (Nigrostriatal)
* Reduced dopamine increases the filter of the basal ganglia - information for movement can not get through
* Cases of Parkinson’s Disease (PD)-like symptoms have been reported
* Similar to the ‘frozen addicts’ who took MPTP by mistake

28
Q

which drugs cause decreased DAT binding ?

A

Methamphetamine and Methcathinone (Meow Meow)

Chronic drug use has long-term behavioural consequences
due to sustained modulation of neurotransmitter systems

28
Q

which drugs cause decreased DAT binding ?

A

Methamphetamine and Methcathinone (Meow Meow)

Chronic drug use has long-term behavioural consequences
due to sustained modulation of neurotransmitter systems